Cancer radiopharmaceuticals Archives - European Biotechnology Magazine

Tag Archive for: Cancer radiopharmaceuticals

Philippe Van Overeem, founder of Van Overeem Nuclear BV

RadioMedix expands thorium-228 supply for 212Pb

Radiopharmaceuticals specialist RadioMedix Inc has secured five-year Thorium-228 supply from Van Overeem, strengthening 212Pb production and Targeted Alpha Therapy pipeline development.

15 December 2025

RadioMedix expands thorium-228 supply for 212Pb

Revier launches with €6M to develop novel cardiom...

Roche licenses Hanmi obesity drug for up to $2.3B

Hansa takes first step toward US Nasdaq listing

Stay up to date every week with the european biotechnology newsletter.

Stay up to date every week with the european biotechnology newsletter.

Tag Archive for: Cancer radiopharmaceuticals